Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Prospective and Multicenter Clinical Investigation Evaluating the Safety and Performance of ABIO3419 in Treating Knee Osteoarthritis.

NCT06611098 is registered in ClinicalTrials.gov with Symatese as lead sponsor.

NCT NCT06611098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06611098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Prospective and Multicenter Clinical Investigation Evaluating the Safety and Performance of ABIO3419 in Treating Knee Osteoarthritis.
Lead sponsor
Symatese
Phase
Not applicable
Overall status
Completed
Start date
February 21, 2025
Completion date
February 13, 2026
Enrollment
134 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthristis